These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32027426)

  • 1. Response to everolimus of a progressive plexiform neurofibroma in Neurofibromatosis type 1.
    Mateos ME; López-Laso E; Vicente J; Ortega R; Vázquez F; Pérez-Navero JL
    Pediatr Int; 2020 Jul; 62(7):857-859. PubMed ID: 32027426
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical impact of selumetinib on pediatric elephantiasis neuromatosa.
    Blegen K; Ortiz-Romero SE; Juarez O; Voeller J
    Pediatr Dermatol; 2022 Sep; 39(5):764-766. PubMed ID: 35739628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental therapy for neurofibromatosis I shows promise: cancer drug shrinks some plexiform neuromas.
    Am J Med Genet A; 2013 Feb; 161A(2):viii-ix. PubMed ID: 23348988
    [No Abstract]   [Full Text] [Related]  

  • 4. Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure".
    Prados MD
    Neuro Oncol; 2014 May; 16(5):617-8. PubMed ID: 24714524
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
    Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
    Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study.
    Weiss B; Widemann BC; Wolters P; Dombi E; Vinks AA; Cantor A; Korf B; Perentesis J; Gutmann DH; Schorry E; Packer R; Fisher MJ
    Pediatr Blood Cancer; 2014 Jun; 61(6):982-6. PubMed ID: 24851266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1.
    Gupta A; Cohen BH; Ruggieri P; Packer RJ; Phillips PC
    Neurology; 2003 Jan; 60(1):130-2. PubMed ID: 12525736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial.
    Zehou O; Ferkal S; Brugieres P; Barbarot S; Bastuji-Garin S; Combemale P; Valeyrie-Allanore L; Sbidian E; Wolkenstein P
    J Invest Dermatol; 2019 Mar; 139(3):718-720. PubMed ID: 30339775
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
    Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
    Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
    Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC
    Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
    Lin V; Daniel S; Forte V
    Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selumetinib in Children with Inoperable Plexiform Neurofibromas.
    Gross AM; Wolters PL; Dombi E; Baldwin A; Whitcomb P; Fisher MJ; Weiss B; Kim A; Bornhorst M; Shah AC; Martin S; Roderick MC; Pichard DC; Carbonell A; Paul SM; Therrien J; Kapustina O; Heisey K; Clapp DW; Zhang C; Peer CJ; Figg WD; Smith M; Glod J; Blakeley JO; Steinberg SM; Venzon DJ; Doyle LA; Widemann BC
    N Engl J Med; 2020 Apr; 382(15):1430-1442. PubMed ID: 32187457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
    Dombi E; Baldwin A; Marcus LJ; Fisher MJ; Weiss B; Kim A; Whitcomb P; Martin S; Aschbacher-Smith LE; Rizvi TA; Wu J; Ershler R; Wolters P; Therrien J; Glod J; Belasco JB; Schorry E; Brofferio A; Starosta AJ; Gillespie A; Doyle AL; Ratner N; Widemann BC
    N Engl J Med; 2016 Dec; 375(26):2550-2560. PubMed ID: 28029918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic Improvement of a Massive Plexiform Neurofibroma After Administration of Selumetinib.
    Passos J; Nzwalo H; Azevedo M; Tavares M; Nunes S
    Pediatr Neurol; 2020 Apr; 105():69-70. PubMed ID: 31917098
    [No Abstract]   [Full Text] [Related]  

  • 15. Giant plexiform neurofibroma causing asymptomatic cervical spinal cord compression in a child with neurofibromatosis type 1.
    Gold JJ; Levy ML; Crawford JR
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23625679
    [No Abstract]   [Full Text] [Related]  

  • 16. Shedding New Light: Novel Therapies for Common Disorders in Children with Neurofibromatosis Type I.
    Pillay-Smiley N; Fletcher JS; de Blank P; Ratner N
    Pediatr Clin North Am; 2023 Oct; 70(5):937-950. PubMed ID: 37704352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for plexiform neurofibromas in patients with NF1.
    Ardern-Holmes SL; North KN
    Lancet Oncol; 2012 Dec; 13(12):1175-6. PubMed ID: 23099008
    [No Abstract]   [Full Text] [Related]  

  • 18. Plexiform neurofibroma of uterus: a rare manifestation of neurofibromatosis 1.
    Shahzad R; Younas F
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S22-3. PubMed ID: 24717994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
    Ullrich NJ; Prabhu SP; Reddy AT; Fisher MJ; Packer R; Goldman S; Robison NJ; Gutmann DH; Viskochil DH; Allen JC; Korf B; Cantor A; Cutter G; Thomas C; Perentesis JP; Mizuno T; Vinks AA; Manley PE; Chi SN; Kieran MW
    Neuro Oncol; 2020 Oct; 22(10):1527-1535. PubMed ID: 32236425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gustatory flushing (auriculotemporal nerve syndrome) in children with neurofibromatosis type 1 and facial plexiform neurofibromas.
    Listernick R; Legius E; Charrow J
    J Pediatr; 2011 Jun; 158(6):1034-1034.e1. PubMed ID: 21329943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.